SEC Filing Document

Company: DUKE Robotics Corp.
Ticker: DUKR
CIK: 1638911
Filing Type: DRS
Document Type: DRS
Date Filed: 2025-12-22
Accession Number: 0001213900-25-124553
Exchange: OTC
SIC Code: 3721
SIC Description: Aircraft
URL: https://www.sec.gov/Archives/edgar/data/1638911/000121390025124553/filename1.htm

Chunk 34 of 51
Word Count: 1281
Character Count: 7931

Document Content:

we fail to effect such reverse stock split of our common stock if necessary to obtain such Nasdaq approval, or if we are not able to uplist our common stock [or list the warrants] for any other reason, we will not be able to consummate the offering and will terminate this offering. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to each underwriter named below and each underwriter named below has severally and not jointly agreed to purchase from us, at the public offering price per Unit less the underwriting discounts set forth on the cover page of this prospectus, the number of Units listed next to its name in the following table: Underwriter Number of Units Maxim Group LLC Total A copy of the underwriting agreement will be filed as an exhibit to the registration statement of which this prospectus is part.

The underwriting agreement
provides that the obligation of the underwriters to purchase all of the Units being offered to the public is subject to specific conditions,
including the absence of any material adverse change in our business or in the financial markets and the receipt of certain legal opinions,
certificates and letters from us, our counsel and the independent auditors. The underwriting agreement also provides that if an underwriter
defaults, the purchase commitments of non-defaulting underwriters may be increased or the offering may be terminated. Subject to the terms
of the underwriting agreement, the underwriters will purchase all of the Units being offered to the public, other than those securities
covered by the over-allotment option described below, if any of these Units are purchased.

The underwriters are offering
the Units, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal matters by their counsel
and other conditions specified in the underwriting agreement. The underwriters reserve the right to withdraw, cancel or modify offers
to the public and to reject orders in whole or in part.

Over-Allotment Option

We have granted to the Representative
an option, exercisable one or more times in whole or in part, not later than 45 days after the date of this prospectus, to purchase from
us up to [_] additional shares of common stock at a price of $[_] per share, and/or warrants to purchase up to [_] additional shares of
common stock at a price of $0.001 per warrant (15% of the shares of common stock and warrants included in the Units offered in this offering,
the warrants to have the same terms as the warrants included in the Units), in each case, less the underwriting discounts and commissions
set forth on the cover of this prospectus in any combination thereof to cover over-allotments, if any. We will be obligated, pursuant
to the option, to sell these additional Units to the underwriters to the extent the option is exercised. If any additional shares of common
stock and/or warrants are purchased, the underwriters will offer the additional shares of common stock and/or warrants on the same terms
as those on which the other Units are being offered hereunder. If this option is exercised in full, the total offering price to the public
will be $[_] and the total net proceeds, before expenses and after the credit to the underwriting commissions described below, to us will

Discounts and Commissions; Expenses

The following table shows
the public offering price, underwriting discount and proceeds, before expenses, to us. The information assumes either no exercise or full
exercise by the Representative of the over-allotment option.

Per Unit Total Without Over- Allotment Option Total
With Full Over- Allotment Option

Public offering price $ $ $

Underwriting discount (8.0%) $ $ $

Proceeds, before expenses, to us $ $ $

We estimate the total expenses
payable by us for this Offering to be approximately $[ ], which amount includes (i) the underwriting discount of $_______(8.0%) assuming
no exercise by the underwriters of their over-allotment option, (ii) reimbursement of the accountable expenses of the Representative
up to $125,000 and (iii) other estimated expenses of approximately $_________, which includes legal accounting printing costs and various
fees associated with the registration of the Units offered hereby.

We have been advised by the
Representative that it proposes to offer the Units offered by us to the public at the public offering price per Unit set forth on the
cover of this prospectus. In addition, the underwriters may offer some of the Units to other securities dealers at such price less a concession
of $ per Unit. After the initial offering, the public offering price and concession to dealers may be changed.

We have paid an expense deposit
of $40,000 to the Representative, which will be applied against the accountable expenses that will be paid by us to the Representative
in connection with this offering. The $40,000 expense deposit will be returned to us to the extent not actually incurred. The underwriting
agreement also provides that in the event the offering is terminated, the $40,000 expense deposit paid to the Representative will be returned
to us to the extent that offering expenses are not actually incurred by the Representative in accordance with Financial Industry Regulation
Authority (“FINRA”) Rule 5110(f)(2)(C).

We have also agreed to reimburse
the Representative for reasonable out-of-pocket expenses not to exceed $125,000 in the aggregate. We estimate that total expenses payable
by us in connection with this offering, other than the underwriting discount, will be approximately $[ ].

Discretionary Accounts

The Representative has advised
us that the underwriters do not intend to confirm sales of the Units offered hereby to any accounts over which they have discretionary
authority.

Indemnification

We have agreed to indemnify
the underwriters against specified liabilities, including liabilities under the Securities Act, and to contribute to payments the underwriters
may be required to make in respect thereof.

Lock-Up Agreements

We and our officers and directors,
and the holders of 3% or more of the outstanding shares of our common stock, as of the effective date of the Registration Statement, have
agreed, subject to limited exceptions, for a period of 180 days after the closing of this offering, not to offer, sell, contract to sell,
pledge, grant any option to purchase, make any short sale or otherwise dispose of, directly or indirectly any shares of our common stock
or any securities convertible into or exchangeable for our common stock either owned as of the date of the underwriting agreement or thereafter
acquired without the prior written consent of the Representative. The Representative may, in its sole discretion and at any time or from
time to time before the termination of the lock-up period, without notice, release all or any portion of the securities subject to lock-up
agreements.

Pricing of this Offering

Prior to this offering, except
for the quotation of our common stock on the OTCQB, there has not been an active market for our common stock and there has been no public
market for our warrants. The public offering price for our Units will be determined through negotiations between us and the underwriters.
Among the factors to be considered in these negotiations will be prevailing market conditions, our financial information, market valuations
of other companies that we and the underwriters believe to be comparable to us, estimates of our business potential, the present state
of our development and other factors deemed relevant.

We offer no assurances that
the public offering price of our Units will correspond to the price at which our common stock will trade in the public market subsequent
to this offering or that an active trading market for our common stock will develop and continue after this offering.

Representative’s Warrants